Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. INSM
INSM logo

INSM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

INSM News

Biotech Landscape Update: Regulatory Approvals and Mergers

3d agoNASDAQ.COM

US Stocks Surge as Oil Prices Plunge Over 10%

6d agoNASDAQ.COM

Insmed's Arikayce Trial Results Show Promise

Mar 23 2026stocktwits

Airlines Surge Amid Easing Iran Tensions

Mar 23 2026CNBC

Oil Price Plunge Boosts Stock Market Gains

Mar 23 2026NASDAQ.COM

Stock Market Rises as Oil Prices Plunge

Mar 23 2026NASDAQ.COM

Insmed's Phase 3b Data Shows Significant Improvement for Arikayce

Mar 23 2026seekingalpha

INSMED STOCK RISES 9% FOLLOWING ENCOURAGING LATE-STAGE TRIAL OUTCOMES FOR LUNG DISEASE TREATMENT

Mar 23 2026moomoo

Insmed Reports Positive Phase 3b ENCORE Study Results for ARIKAYCE

Mar 23 2026PRnewswire

Insmed Reports Positive Results for ARIKAYCE in Phase 3b ENCORE Study

Mar 23 2026Newsfilter

S&P 500 Futures Increase in Pre-Market Activity; Insmed and Mobileye Global Take the Lead

Mar 23 2026Barron's

RTW Investments Takes New Stake in Apellis Pharmaceuticals

Mar 22 2026Yahoo Finance

RTW Investments Increases Stake in Cogent Biosciences by $116 Million

Mar 22 2026Yahoo Finance

Analysis of IBB ETF Trading Dynamics

Mar 20 2026NASDAQ.COM

Analysis of IBB ETF Trading Dynamics

Mar 11 2026NASDAQ.COM

INSM Stock 52-Week Highs and Lows Analysis

Mar 05 2026NASDAQ.COM